🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Capsule(s) Serving Size
50 Servings
Other Combinations Product Type
25% Evidence Coverage

Supplement Facts — Evidence Check

150 mg
📊 Market median: 120.0mg (440 products) 📚 187 studies (Tier A: 1, B: 71)
This product: 150mg
Gotu Kola
125 mg
Fo-Ti
120 mg
Club Moss
500 mcg
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 230mg UL 3000mg
Dimethylaminoethanol
75 mg
Vinpocetine
54 mg
Rosemary
50 mg

Other Ingredients

Cellulose Diatomaceous Earth

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (80% of products) Nutrient (4% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Directions: For adults, take two (2) capsules daily, more if needed.

⚠️ Warnings & Precautions

We do not suggest you take this product the same day as any pharmaceutical, Adderall, Ritalin, or stimulant type drugs that are often used for ADHD. As a reminder, discuss the supplements and medications you take with your health care providers.

Keep out of reach of children store in a dry place and avoid excessive heat.

🧪 Formulation Notes

No: chemical fillers or binders, artificial coloring, artificial flavor, preservatives, yeast, corn, milk or milk derivatives, lactose, salt, sodium, soy, sugar, gluten, starch or wheat.

From a GMP Facility

Brain Health with Huperzine A & Gingko

Our brain is the control center of all human function. Despite weighing only about three pounds, the human brain is composed of about 100 billion cells functioning together in a complex system that dwarfs any super computer.

Additional Information

Keep out of reach of children store in a dry place and avoid excessive heat.

Product Details

DSLD Entry Date 2025-09-25
Product Type Other Combinations
Form Capsule
DSLD ID 338622
Data Updated 2026-04-11

Research Evidence

183 Research Sources
55 Avg Quality Score
86 Systematic Review
78 Meta Analysis
7 Other
4 Clinical Trial
2 Rct
2 Narrative Review
2 Regulatory Source
1 Openfda Safety
A Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2026
B Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2009
B Ginkgo biloba for tinnitus
Meta Analysis The Cochrane database of systematic reviews 2013
B Ginkgo biloba for tinnitus
Systematic Review The Cochrane database of systematic reviews 2022
B Ginkgo biloba for prevention of dementia: a randomized controlled trial
Rct JAMA 2008
B Effectiveness and safety of ginkgo biloba preparations in the treatment of Alzheimer's disease: A systematic review and meta-analysis
Systematic Review Frontiers in aging neuroscience 2023
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2013
B The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis
Systematic Review Frontiers in aging neuroscience 2020
B Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2026
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2009
View all evidence for Ginkgo →

Compare Similar Products

View all Ginkgo products →